Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Meier

Showing results (301-310 of 305) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 305 results.
Cell|May 31, 2020
Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor CellsPing-Pui Wong, José M Muñoz-Félix, Maruan Hijazi, et al.
Nature Communications|March 6, 2026
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapyWinnie Fernando, Jarama Clucas, Alberto Rizzo, et al.
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Cell Death and Differentiation|January 25, 2018
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018Lorenzo Galluzzi, Ilio Vitale, Stuart A Aaronson, et al.
Cell Death and Differentiation|April 26, 2023
Apoptotic cell death in disease-Current understanding of the NCCD 2023Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Pageof 31

Showing results (301-310 of 305) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 305 results.
Cell|May 31, 2020
Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor CellsPing-Pui Wong, José M Muñoz-Félix, Maruan Hijazi, et al.
Nature Communications|March 6, 2026
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapyWinnie Fernando, Jarama Clucas, Alberto Rizzo, et al.
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Cell Death and Differentiation|January 25, 2018
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018Lorenzo Galluzzi, Ilio Vitale, Stuart A Aaronson, et al.
Cell Death and Differentiation|April 26, 2023
Apoptotic cell death in disease-Current understanding of the NCCD 2023Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Pageof 31